Dual Blockade of CD44v6 and PI3K Undermines Colorectal Cancer Stem Cell Reprogramming
A preclinical study reports that combining the CD44v6 inhibitor AMC303 with the dual PI3K/mTOR inhibitor Apitolisib suppresses HGF-driven reprogramming and ...
A preclinical study reports that combining the CD44v6 inhibitor AMC303 with the dual PI3K/mTOR inhibitor Apitolisib suppresses HGF-driven reprogramming and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine